Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Postoperative Cognitive Dysfunction in Geriatric Orthopaedic Surgery
NCT04321746Phase 4Completed
- Sponsor
- Assiut University
- Start
- Dec 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketamine in Post-operative cognitive dysfunction (POCD) (2 arms), sponsored by Assiut University. Primary endpoint: Postoperative Cognitive Dysfunction at 1 day. Started Dec 2020; status: completed.
02
Drugs
ketamine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT04321746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04321746.